Rankings
▼
Calendar
SNDX FY 2020 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SNDX
Syndax Pharmaceuticals, Inc.
$2B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+0.0% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$71M
-4708.2% margin
Net Income
-$73M
-4816.7% margin
EPS (Diluted)
$-1.77
Cash Flow
Operating Cash Flow
-$71M
Free Cash Flow
-$71M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$301M
Total Liabilities
$48M
Stockholders' Equity
$252M
Cash & Equivalents
$115M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
+0.0%
Gross Profit
$2M
$2M
+0.0%
Operating Income
-$71M
-$58M
-24.1%
Net Income
-$73M
-$56M
-30.6%
← Q4 2019
All Quarters
Q1 2020 →